ABSTRACT
Oxidative stress is generated by reactive oxygen species (ROS) produced in response to metabolic activity and environmental factors. Increased oxidative stress is associated with the pathophysiology of a broad spectrum of inflammatory diseases. Cellular response to excess ROS involves the induction of antioxidant response element (ARE) genes under control of the transcriptional activator Nrf2 and the transcriptional repressor Bach1. The development of synthetic small molecules that activate the protective anti-oxidant response network is of major therapeutic interest. Traditional small molecules targeting ARE-regulated gene activation (e.g., bardoxolone, dimethyl fumarate) function by alkylating numerous proteins including Keap1, the controlling protein of Nrf2. An alternative is to target the repressor Bach1. Bach1 has an endogenous ligand, heme, that inhibits Bach1 binding to ARE, thus allowing Nrf2-mediated gene expression including that of heme-oxygenase-1 (HMOX1), a well described target of Bach1 repression. In this report, normal human lung fibroblasts were used to screen a collection of synthetic small molecules for their ability to induce HMOX1. A class of HMOX1-inducing compounds, represented by HPP-4382, was discovered. These compounds are not reactive electrophiles, are not suppressed by N-acetyl cysteine, and do not perturb either ROS or cellular glutathione. Using RNAi, we further demonstrate that HPP-4382 induces HMOX1 in an Nrf2-dependent manner. Chromatin immunoprecipitation verified that HPP-4382 treatment of NHLF cells reciprocally coordinated a decrease in binding of Bach1 and an increase of Nrf2 binding to the HMOX1 E2 enhancer. Finally we show that HPP-4382 can inhibit Bach1 activity in a reporter assay that measures transcription driven by the human HMOX1 E2 enhancer. Our results suggest that HPP-4382 is a novel activator of the antioxidant response through the modulation of Bach1 binding to the ARE binding site of target genes.
Subject(s)
Antioxidant Response Elements , Basic-Leucine Zipper Transcription Factors/antagonists & inhibitors , Basic-Leucine Zipper Transcription Factors/metabolism , Fanconi Anemia Complementation Group Proteins/antagonists & inhibitors , Fanconi Anemia Complementation Group Proteins/metabolism , Heme Oxygenase-1/genetics , Transcriptional Activation , Chromatin Immunoprecipitation , Fibroblasts/drug effects , Heme/metabolism , Heme Oxygenase-1/metabolism , Humans , Oxidative StressABSTRACT
In our previous study YFa (YGGFMKKKFMRFa), a chimeric peptide of met-enkephalin and FMRFa, not only produced analgesia but also did not let the tolerance develop. In the continuation of the same study, Phe4 is chlorinated so as to assess the effect of chlorination on the conformation, lipophilicity and analgesia of chimeric peptide [p-Cl Phe(4)] YFa. Not only does the chlorination increase the lipophilicity but also enhances the propensity of [p-Cl Phe(4)] YFa to form alpha helix in comparison of YFa in presence of membrane mimicking solvent trifluoroethanol (TFE). This increase in lipophilicity and helix-forming ability results in more bioavailability and naloxone-reversible analgesia by [p-Cl Phe(4)] YFa. Though analgesia produced by [p-Cl Phe(4)] YFa is more than YFa at all doses, there is sudden decrease in analgesia at 45 and 60 min at 60 mg/kg. This sudden decrease of analgesia seems to be due to desensitization of opioid receptors.
Subject(s)
Analgesia , Analgesics, Opioid/pharmacology , Enkephalin, Methionine/pharmacology , FMRFamide/pharmacology , Oligopeptides/pharmacology , Pain/physiopathology , Analgesics, Opioid/chemistry , Animals , Circular Dichroism , Enkephalin, Methionine/chemistry , Enkephalin, Methionine/physiology , FMRFamide/chemistry , FMRFamide/physiology , Male , Mice , Octanols , Oligopeptides/chemistry , Pain/metabolism , Protein Structure, Secondary , Solubility , WaterABSTRACT
Liposomes presenting fertilinbeta peptides are inhibitors of mouse in vitro fertilization. We undertook a study of the relationship between IC(50) and mole fraction of fertilinbeta in the liposome, and the size dependence of inhibition of fertilization to understand the mechanism of their inhibition. Our results indicate that a small number of multivalent contacts are required for efficient attachment of inhibitor to receptor on the target membrane, and that, as designed, the liposomes target the egg membrane but not the sperm membrane. The size dependence of the liposome inhibition demonstrates that the liposomes physically block access of the sperm to the egg membrane thereby preventing sperm binding to all egg receptors not just the fertilinbeta receptor.